LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Publisher: Springer Verlag
Languages: English
Types: Article
Subjects:

Classified by OpenAIRE into

mesheuropmc: health care economics and organizations
Aims \ud To identify cost-of-illness studies of Type 1 diabetes mellitus (Type 1 DM) in the United \ud Kingdom (UK) and review this literature to estimate the current cost of Type 1 DM to the UK \ud National Health Service. \ud \ud Methods \ud Bibliographic databases and grey literature were systematically searched to identify all \ud published and unpublished reporting of the costs of Type 1 DM in the UK. Studies were \ud excluded if they did not present cost information from the UK or did not disaggregate \ud information by diabetes type. Three grey literature sources and 11 published studies were \ud identified for inclusion in the literature review. \ud \ud Results \ud The included studies and reports covered topics including the overall cost of Type 1 DM, \ud costs of individual diabetic complications and costs of specific interventions for Type 1 DM. \ud The most recent published estimate of the cost of Type 1 DM was over 15 years old, and \ud although this estimate has been inflated to current prices the estimate is not adjusted for \ud changes to treatment pathways over this period and is therefore not considered an accurate \ud estimate of current costs of Type 1 DM. \ud \ud Conclusions \ud There is not a recently published estimate of the cost of Type 1 DM in the UK therefore it is \ud recommended that an up-to-date national, comprehensive COI study should be conducted. \ud Recommendations for the format of this study are made, including extending the scope to \ud cover recent treatment developments and resource use where diabetes is a subsidiary \ud diagnosis.
  • No references.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article